Explore our grantees and awardees

Grant category: Research Grants in open competition

Year: 2022

Geography: Germany

Michael Bader’s project aims to develop novel angiotensin-converting enzyme 2 (ACE2) inhibitors to be applied to the skin for treating inflammatory skin diseases.

Alpha-melanocyte-stimulating hormone (α-MSH) acting through its receptor, melanocortin 1 receptor (MC1R), is the most important regulator of melanogenesis (i.e., the production of melanin, the pigment of the skin) and also exerts significant anti-inflammatory actions in the skin. Therefore, MC1R may be a significant treatment target for inflammatory skin diseases and for prevention of melanoma, and several agonists are already clinically approved or currently being developed.

Michael and his group have discovered that ACE2 limits melanogenesis in mouse and human skin by degrading α-MSH. Thus, ACE2 inhibition in the skin may be a novel strategy for dermatological diseases by stabilizing α-MSH and thereby activating MC1R.

However, ACE2 is also a protective enzyme in the circulation limiting the actions of the blood pressure regulatory system, the renin-angiotensin system. Therefore, systemic inhibition of ACE2 may cause severe side-effects, making topical application of ACE2-inhibitors preferable.

Michael and his team have already tested a number of available ACE2-inhibiting compounds, but none were suitable for topical application “as-is”. In this project, they will chemically design variants of known ACE2 inhibitors to optimize for skin permeation and test them in a mouse model of vitiligo. If they are successful, these compounds can also be tested in other inflammatory skin diseases, such as acne and psoriasis, for melanoma prevention, and perhaps even for cosmetic applications, such as skin tanning and prevention of hair greying.

Grant category: Research Grants in open competition

Year: 2022

Geography: USA

Cutaneous T-cell lymphoma (CTCL), a cancer of white blood cells, can look like atopic dermatitis. This project from Larisa Geskin aims to develop and validate a screening test for patients with atopic dermatitis (AD) which will aid in identifying undiagnosed CTCL in these patients.

Interleukin-4 (IL-4) and interleukin-13 (IL-13) are essential cytokines (i.e., signaling molecules released from cells to the environment in order to affect other cells), in the pathogenesis of AD. Targeting these cytokines with antibodies such as dupilumab or tralokinumab has proven to be highly effective for therapy of AD.

However, patients with AD may have an increased risk for lymphoma, especially CTCL. There are numerous reports of patients with AD who received dupilumab and later developed CTCL, lethal in some cases. Therefore, therapies targeting IL-4/IL-13 are currently contraindicated for patients with CTCL. However, differentiation between AD and CTCL is difficult because of similar manifestations in the skin and lack of specific markers (i.e., molecules that are uniquely present or expressed in a given condition) for these diseases.

In their preliminary studies Larisa and her team have screened the blood of patients with biopsy-confirmed CTCL and AD for 18 highly selected potential biomarkers using an efficient screening method. Of the 18 tested biomarkers, 9 demonstrated sensitivity and specificity potentially adequate to differentiate CTCL from benign dermatoses. These data serve as a proof of principle and justify further studies, as described in this proposed project, to test a broader set of biomarkers to find the most promising biomarker panel with the highest sensitivity and specificity to develop a simple, robust and inexpensive test, which may be widely accessible to all treating physicians before initiating therapy for AD.

Grant category: Research Grants in open competition

Year: 2022

Geography: Denmark

Gregers Andersen’s project aims to understand the role of disease-related mutations of a central inflammation-regulating protein on immune cells in systemic lupus erythematosus (SLE).

Systemic lupus erythematosus is a severe autoimmune disease in which our immune system is erroneously activated. This leads to inflammation that may destroy tissue, such as the kidney. SLE often manifests itself with visible skin rashes that are difficult to treat and debilitating for the patient. Current options for treatment of SLE are insufficient and still rely heavily on steroids as the mainstay of treatment.

Both environmental and genetic factors contribute to SLE pathogenesis. The strongest association between SLE and the information encoded in our genetic material is observed for a specific mutation in a gene called ITGAM. This gene codes for a protein called αMβ2 located at the surface of our immune cells. When the αMβ2 protein recognizes specific proteins on other cells, the immune cell contributes to dampening inflammation. When the ITGAM gene is mutated, the immune cells are less efficient in suppressing inflammation.

Using the most powerful microscope available, Gregers’ research project will investigate in atomic detail how the mutation interferes with the normal function of the αMβ2 protein. Furthermore, the effects of a new antibody capable of increasing the activity of αMβ2 will be exhaustively investigated. Experiments comparing the effects of this antibody on immune cells from healthy and SLE individuals will be central in deciding whether the antibody is a candidate for a new type of therapeutic agent.

Grant category: Education and Awareness Grants

Year: 2022

Geography: Denmark

The Bloom Festival is celebrated annually and places a focus on acknowledging the wonders of nature and science – the festival is held each year in Søndermarken on Frederiksberg. The festival has existed since 2017, with the LEO Foundation offering funding support since 2019.  

The festival is organized by ADBC, which has success in running other alike initiatives, such as the annual Golden Days festival. The annual Bloom Festival is a contribution to strengthening the landscape of STEM-initiatives in Denmark, and functions as an innovative event which aims to enlighten us on the universe, the world, and ourselves. 

By uniting the best from the worlds of festivals and science, Bloom aims to tackle Life’s greatest questions through debates, talks, laboratories, conversations, and nature walks. 

More information

Grant category: Standalone grants

Year: 2022

Geography: Denmark

The Institute for Immunology and Microbiology is the host of the LEO Foundation’s major strategic initiative, the LEO Foundation Skin Immunology Center (SIC). ISIM has been established with flow cytometry and single cell sequencing as main areas of expertise and serves as a platform for integrative cell analysis.  

ISIM provides local and external research groups and biotech companies with access to highly specialized equipment for analysis using flow cytometry and state-of-the-art single cell sequencing, as well as highly specialized staff who are experts at analyzing samples in complex projects.  

In support of ISIM the LEO Foundation provides new equipment to the organization to upgrade technological options for cell and single cell analysis, to make it possible to implement new methods using new and existing equipment together, and to help ensure that the core facility can support experiments in the entirety of their pipeline – from initial idea formation to full-scale experiments.  

More information

Grant category: Standalone grants

Year: 2022

Geography: Denmark

SIC Springtime School is hosted annually by the LEO Foundation Skim Immunology Research Center (SIC) and has shown to be a great success over the two previous years. The international school is held at Hornbækhus on the North Coast of Zealand and forms part of SIC’s educational and career development activities – in 2022 representing 86 speakers, international students, and postdoc participants.  

The SIC Springtime School offers participants the opportunity to interact with leading scientists, providing for rich and positive learning experiences.  

More information

Grant category: Standalone grants

Year: 2022

Geography: Denmark

The SIC PhD Program aims to nurture the development of upcoming skin immunologists and to further tap into the collaborative possibilities of the research groups within the by the LEO Foundation Skim Immunology Research Center (SIC). 

The program features a 1+3-year structure for five PhD studies at the center. In their first year, students are onboarded into the program as Research Assistants, before eventually enrolling as full-time PhD students in their year two. 

The program sets to strengthen not only the collaborative nature of the center, but also allows for potentially high-gain projects to be set into motion. 

Grant category: Education and Awareness Grants

Year: 2022

Geography: Denmark

Astra has existed as an organization since 2015-2017 and was born out of a merger between Danish Science Factory, ‘Science Talenter’ and the publicly funded NTS-center (Det Nationale Center for Undervisning i Natur, Teknik og Sundhed). Astra defines its mission as to bring together relevant actors to progress and expand upon the quality and framing of the education of the natural sciences. 

The LEO Foundation has previously supported numerous of Astra’s initiatives and activities, and with this grant, funding is dispersed between 3 of Astra’s largest programs: ‘Unge Forskere‘ (Young Scientists) an annual research-idea and talent competition for children and youths in elementary- and high -school with a passion for science and technology, ‘Big Bang‘ an annual science conference for professionals within teaching and communication of STEM and science topics, and ‘Science Talenter’ (Science Talents) which organizes science camps for the oldest pupils from elementary school as well as A-level students with a special interest in and talent for STEM-topics. 

Grant category: Education and Awareness Grants

Year: 2022

Geography: Denmark

Lex.dk is an association formed by the Danish Universities, Gyldendal A/S, G.E.C. Gad’s Foundation and the Danish Society for Language and Literature, which was originally established around the online version of ‘Den Store Danske’, Gyldendal’s well-renowned encyclopedia. The encyclopedia focuses on nature, culture, science, and society with a national point of departure and a global outlook.  

Lex.dk has become the go-to resource for dissemination of validated research information from many areas of expertise and is written by researchers and experts. The encyclopedia serves as an important source to the broader public, but rather importantly, also to pupils in elementary school and A-level students when compiling information for assignments and reports.  

Lex.dk is unique in that there is no other encyclopedia source in Danish that provides a broad perspective on health and health sciences through focused articles. This grant supports updating and significantly expanding content on health and health research through collaboration with the Norwegian counterpart. This means that newly revised and well-researched information on will become available to the general Danish public online. 

More information

Grant category: Research Grants in open competition

Year: 2022

Geography: Netherlands

The aim of Ellen’s project is to improve the understanding of the role of skin protein filaggrin (FLG) in regulating and controlling epidermal keratinocyte robustness and differentiation.

Ever since the discovery that loss-of-function mutations in the FLG gene are the main risk factor for developing Atopic Dermatitis (AD), many studies have aimed to relate the presence or absence of FLG to processes involved in skin homeostasis. The filaggrin protein is comprised of several repetitive elements as well as two unique domains, A and B. While many mutations in the filaggrin monomers are known to be important in AD, the role of the A and B domains have been less studied.

Previous investigation, featuring collaborator and postdoctoral fellow Jos P.H. Smits, discovered that mutations in these domains affect the expression of genes that are important for terminal differentiation of epidermal keratinocytes. The terminal differentiation of keratinocytes is important for the formation of the skin barrier. In this project, the team want to expand initial findings into elaborate studies using 3D skin organoids, also called “human skin equivalents” combined with in-depth molecular and functional analyses. Ellen’s group has developed many of these 3D skin equivalents to resemble both the structure and environment of real skin. By exposing the skin equivalents to relevant environmental factors, they will study how mutations in the filaggrin A and B domains affect keratinocyte differentiation and terminal fate and ultimately the overall skin barrier function. The hope is to identify potential new targets for therapeutic interventions in AD by modifying the expression of filaggrin and thereby regulating the barrier function of the skin.